Free Trial

Sivik Global Healthcare LLC Lowers Stake in Surgery Partners, Inc. (NASDAQ:SGRY)

Surgery Partners logo with Medical background

Sivik Global Healthcare LLC cut its stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 8.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 230,000 shares of the company's stock after selling 20,000 shares during the period. Surgery Partners accounts for approximately 3.1% of Sivik Global Healthcare LLC's portfolio, making the stock its 12th largest position. Sivik Global Healthcare LLC owned 0.18% of Surgery Partners worth $7,415,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. KBC Group NV lifted its holdings in shares of Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company's stock valued at $77,000 after purchasing an additional 576 shares during the last quarter. DekaBank Deutsche Girozentrale raised its stake in Surgery Partners by 102.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company's stock valued at $80,000 after buying an additional 1,375 shares during the last quarter. Quarry LP boosted its holdings in Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company's stock worth $73,000 after acquiring an additional 1,760 shares in the last quarter. EntryPoint Capital LLC grew its stake in shares of Surgery Partners by 257.1% in the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company's stock worth $191,000 after acquiring an additional 4,607 shares during the last quarter. Finally, Creative Planning bought a new position in shares of Surgery Partners during the third quarter valued at $258,000.

Surgery Partners Stock Performance

Shares of Surgery Partners stock traded down $0.73 on Thursday, hitting $24.77. 2,397,336 shares of the company's stock were exchanged, compared to its average volume of 949,287. Surgery Partners, Inc. has a 1 year low of $22.25 and a 1 year high of $36.92. The company has a 50-day simple moving average of $30.88 and a 200-day simple moving average of $28.47. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.69 and a current ratio of 1.83. The stock has a market capitalization of $3.15 billion, a PE ratio of -50.90, a PEG ratio of 2.34 and a beta of 2.76.

Wall Street Analyst Weigh In

Several analysts recently commented on SGRY shares. StockNews.com downgraded shares of Surgery Partners from a "hold" rating to a "sell" rating in a research report on Wednesday, August 7th. Cantor Fitzgerald reiterated an "overweight" rating and set a $43.00 price target on shares of Surgery Partners in a report on Friday, October 4th. KeyCorp assumed coverage on Surgery Partners in a research report on Friday, October 11th. They issued a "sector weight" rating on the stock. Macquarie decreased their target price on Surgery Partners from $35.00 to $34.00 and set an "outperform" rating for the company in a research report on Wednesday. Finally, Citigroup dropped their price target on shares of Surgery Partners from $38.00 to $36.00 and set a "buy" rating on the stock in a report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $40.00.

Get Our Latest Stock Report on Surgery Partners

About Surgery Partners

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Featured Articles

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Should you invest $1,000 in Surgery Partners right now?

Before you consider Surgery Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.

While Surgery Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines